Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Nutr Cancer. 2016 Sep 16;68(8):1262–1268. doi: 10.1080/01635581.2016.1224367

Association between dietary inflammatory index and gastric cancer risk in an Italian case-control study

Nitin Shivappa 1,2,3, James R Hébert 1,2,3,4, Monica Ferraroni 5, Carlo La Vecchia 5, Marta Rossi 5
PMCID: PMC5154551  NIHMSID: NIHMS833206  PMID: 27636679

Abstract

Background

In this study, we explored the association between the dietary inflammatory index (DII) and gastric cancer risk in an Italian case-control study.

Materials and Methods

Cases were 230 patients with incident, histologically confirmed cases of gastric cancer from the Greater Milan area, northern Italy. Controls were 547 frequency-matched subjects admitted to the same network of hospitals as cases for a wide spectrum of acute, non-neoplastic conditions. The DII was computed using a reproducible and valid 78-item food frequency questionnaire. Odds ratios (OR) were estimated through logistic regression models conditioned on age and sex and adjusted for recognised confounding factors, including total energy intake.

Results

Subjects with the most pro-inflammatory diet had a higher risk of gastric cancer compared to subjects with the most anti-inflammatory diet (ORQuartile4vs1= 2.35, 95% confidence interval, 1.32, 4.20; p-trend=0.004).

Conclusion

These results indicate that a pro-inflammatory diet, as indicated by higher DII score, was associated with gastric cancer risk.

Keywords: DII, diet, inflammation, gastric cancer, case-control, Italy

Introduction

Gastric cancer represents the fifth most common cancer and the third-leading cause of cancer death worldwide, with almost 1 million cases and over 700,000 deaths estimated in 2012 (1). In Italy, it is the fourth most common cause of cancer death, after lung, colorectal and breast cancers (2). The major recognized risk factor is Helicobacter pylori infection; however, considerable evidence is accumulating on the role of diet and nutrition in the risk of gastric cancer (36).

Various dietary components have different effect on inflammation (79). The relation between diet and gastric cancer has been studied widely (5, 10); however, the possible relation between inflammation deriving from dietary exposure and gastric cancer risk has not yet been investigated.

Chronic inflammation is a persistent condition in which tissue destruction and repair occur simultaneously (11, 12). Evidence from previous studies suggests an important role of chronic inflammation in gastric cancer (1315). A meta-analyses of 5 case-control studies, showed polymorphism of interleukin (IL)-17A G197A to be associated with gastric cancer (16). In another meta-analyses, increased pre-treatment serum C-reactive protein level (≥10mg/L) was significantly associated with poor prognosis in gastric cancer patients, either in early or advanced stages (17).

A literature-derived dietary inflammatory index (DII) was developed to assess the inflammatory potential of an individual’s diet (18). The DII has been validated with various inflammatory markers, including C-reactive protein (19), interleukin-6 (20, 21), and homocysteine (21). The DII has been shown to be associated with metabolic syndrome and it’s components (2224), anthropometric measurements and cardiovascular disease in Spain (2527); bone mineral density among postmenopausal women in Iran (28). Concerning digestive tract cancers, DII is related to an increased risk of colorectal cancer three cohort studies in from the USA (2931) and in two cancer case-control studies, in Spain (32) and Italy (33), esophageal squamous cell cancer in three case-control studies (3436) and pancreatic cancer in one case-control study(37). In addition to cancer incidence DII also was found to be associated with digestive cancer mortality in three cohort studies (3840).

This study examined the association between the DII and gastric cancer risk in a case-control study conducted in Italy (41). This is the first study to explore this association.

Methods

Design and Participants

Data were from a case-control study of gastric cancer conducted between 1997 and 2007 in the Greater Milan area, Northern Italy (41). Cases were 230 patients (143 men and 87 women; median age, 63 y; range, 22–80 y), admitted to major teaching and general hospitals in the study area with incident, histologically confirmed gastric cancer (Ninth Revision of the International Classification of Diseases: 151.0–151.9), diagnosed no longer than 1 y before the interview, and with no previous diagnosis of cancer. The control group included 547 patients (286 men and 261 women; median age, 63 y; range, 22–80 y), frequency matched to cases by age and sex (with a ratio of 2:1 for men and 3:1 for women), admitted to the same hospitals as cases for a wide spectrum of acute, non-neoplastic conditions that are unrelated to known or potential risk factors for gastric cancer. Additionally we excluded subjects who were admitted for conditions associated with long-term dietary modifications such as diabetes and cardiovascular diseases. Among controls, 20% were admitted for traumas, 23% for other orthopaedic conditions, 22% for acute surgical, and 35% for other miscellaneous disorders. Less than 5% of cases and controls approached refused to be interviewed.

Trained interviewers collected information during their hospital stay using a structured questionnaire on socio-demographic characteristics, anthropometric characteristics, life-style habits, including tobacco smoking and alcohol drinking, personal medical history. Subjects’ usual diet prior to cancer diagnosis or hospital admission (for controls) was assessed using an interviewer-administered food frequency questionnaire (FFQ), consisting of 78 items on foods, including the most common Italian recipes, and 5 items on alcoholic beverages. Subjects were asked to indicate the average weekly frequency of consumption of each dietary item; intakes lower than once a week, but at least once a month, were coded as 0.5 per week. Nutrient and total energy intake was determined using an Italian food composition database. The FFQ showed reproducibility (42, 43) and validity (44) with Spearman correlation coefficients between 0.60 and 0.80 for most food items and nutrients.

In order to compute the DII score, dietary information for each study participant were first linked to the regionally representative database that provided a robust estimate of a mean and a standard deviation for each of the 45 parameters (i.e., foods, nutrients, and other food components) considered (18). These parameters then were used to derive the subject’s exposure relative to the standard global mean as a z-score, derived by subtracting the mean of the regionally representative database from the amount reported, and dividing this value by the parameter’s standard deviation. To minimize the effect of “right skewing,” this value was converted to a centered percentile score, which was then multiplied by the respective food parameter effect score (derived from a literature review on the basis of 1943 articles). All of these food parameter-specific DII scores were then summed to create the overall DII score for every subject in the study. The DII computed on this study’s FFQ includes data on 31 of the 45 possible food parameters comprising the DII: carbohydrates, proteins, fats, alcohol, fibers, cholesterol, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, omega 3, omega 6, niacin, thiamin, riboflavin, vitamin B6, iron, zinc, vitamin A, vitamin C, vitamin D, vitamin E, folic acid, beta carotene, anthocyanidins, flavan3ols, flavonols, flavanones, flavones, isoflavones, caffeine, and tea.

The DII was analysed both as a continuous variable, with each point corresponding to 10% of its range (4.78 to −4.71), and by quartiles of exposure computed among controls. Odds ratios (ORs) and the corresponding 95% confidence intervals were estimated using conditional logistic regression models conditioned on study centre and quinquennia of age, and adjusted for education (<7, 7–11, ≥12 years, categorically), year of interview, body mass index (BMI) (<20, 20–24.9, 25–29.9, ≥30 kg/m2), smoking (never smoker, ex-smoker, current smoker of <15 and ≥15 cigarettes/day, categorically), and total energy intake (quintiles; <1569, 1569–1915, 1916–2229, 2230–2601, >2601 kcals). Stratified analyses were carried out according to sex, age (<65, ≥65 years), education (<7 and ≥7y), BMI (<25, ≥25 kg/m2) and tobacco smoking (never and former smokers and current smokers). Given the small number subjects with family history of gastric cancer, this variable was not included as a covariate in the model. Linear tests for trend were performed using the median value within each quartile as an ordinal variable (45). Statistical tests were performed using SAS® 9.3 (SAS Institute Inc., Cary, NC).

Results

The distribution of 230 gastric cancer cases and 547 controls according to age, education, and other selected variables is presented in Table 1. By design, cases and controls had a similar age (p value=0.99) and sex (p value=0.01) distribution. Cases were more frequently current and ex-smokers and no differences were observed with education and BMI.

Table 1.

Distribution of 230 gastric cancer cases and 547 controls according to selected variables, Italy, 1997–2007

Cases Controls

N. (%) N. (%)
Sex
 Male 143 (62.2) 286 (52.3)
 Female 87 (37.8) 261 (47.7)
Age (years)
 <50 39 (17.0) 97 (17.7)
 50–60 58 (25.2) 137 (25.1)
 60–70 86 (37.4) 202 (36.9)
 ≥70 47 (20.4) 111 (20.3)
Education (years)a
 <7 95 (41.8) 236 (43.5)
 7–11 86 (37.9) 174 (32.0)
 ≥12 46 (20.3) 133 (24.5)
Body mass index (kg/m2)a
 <20 12 (5.3) 33 (6.1)
 20–25 106 (46.9) 216 (39.4)
 25–30 82 (36.3) 223 (40.9)
 ≥30 26 (11.5) 73 (13.6)
Smoking
 Never smokers 96 (41.8) 261 (47.8)
 Ex-smokers 75 (32.8) 167 (30.6)
 Current smokers
  <15 cigarettes/day 25 (10.9) 49 (9.0)
  ≥15 cigarettes/day 33 (14.4) 69 (12.6)
a

The sum does not add up to a total of 100% because of some missing values.

Characteristics of control subjects across quartiles of DII are provided in Table 2. There were small non-significant differences in socio-demographic characteristics, anthropometric measures, and lifestyle habits across quartiles of DII.

Table 2.

Participants’ characteristics across quartiles of dietary inflammatory index (DII) among 547 controls. Italy, 1997–2007.

Characteristics DII quartiles
< −1.47 −1.47,−0.14 −0.13,1.49 >1.49 P-Valueb

N (%) N (%) N (%) N (%)
Sex 0.82
 Male 74 (54.4) 73 (52.9) 72 (52.9) 67 (48.9)
 Female 62 (45.6) 65 (47.1) 64 (47.1) 70 (51.1)
Age (years) a 0.24
 <50 26 (19.1) 21 (15.2) 21 (15.4) 29 (21.2)
 50–60 38 (27.9) 44 (31.9) 29 (21.3) 26 (19.0)
 60–70 50 (36.7) 48 (34.8) 51 (37.5) 53 (38.7)
 ≥70 22 (16.2) 25 (18.1) 35 (25.7) 29 (21.2)
Education (years) 0.56
 <7 54 (39.7) 58 (42.0) 56 (41.2) 68 (49.6)
 7–11 49 (36.0) 49 (35.5) 44 (32.4) 36 (26.3)
 >11 33 (24.3) 31 (22.5) 36 (26.5) 33 (24.1)
Body mass index 0.63
 <20 8 (5.9) 8 (5.8) 10 (7.4) 9 (6.6)
 20 to <25 58 (42.6) 49 (35.5) 47 (34.6) 62 (45.3)
 25 to <30 56 (41.2) 62 (44.9) 59 (43.4) 46 (33.6)
 ≥30 14 (10.3) 19 (13.8) 20 (14.7) 20 (14.6)
Smoking 0.95
 Never smokers 66 (48.5) 63 (45.7) 65 (48.2) 67 (48.9)
 Ex-smokers 42 (30.9) 44 (31.9) 44 (32.6) 37 (27.0)
 Current smokers
  <15 14 (10.3) 11 (8.0) 11 (8.2) 13 (9.5)
  ≥15 14 (10.3) 20 (14.5) 15 (11.1) 20 (14.6)
a

Chi-square test for categorical variables

Table 3 shows the ORs of gastric cancer for the highest versus the lowest DII quartile, as well as for an increment of 1 unit of DII, overall and in strata of selected covariates. Subjects in the upper quartiles of DII had an increased OR for gastric cancer compared to subjects in the lowest quartile (ORQuartile4vs1= 2.35, 95% C.I=1.32, 4.20; Ptrend=0.004). A positive association also was observed when considering continuous OR (1.19, 95% CI=1.06, 1.34; P value=0.004). Apparently stronger associations were observed between DII and gastric cancer among females (ORQuartile4vs1= 2.57, CI 1.07, 6.18; Ptrend=0.04), subjects aged <65years (ORQuartile4vs1= 2.85, CI 1.28, 6.34; Ptrend=0.01), less educated (ORQuartile4vs1= 3.64, CI 1.33, 9.96; Ptrend=0.01), non-overweight (ORQuartile4vs1= 2.50, CI 1.12, 5.61; Ptrend=0.01) and smokers (ORQuartile4vs1= 2.62, CI 1.16, 5.92; Ptrend=0.03), in the absence, of significant heterogeneity.

Table 3.

Odds ratios (OR) of gastric cancer and corresponding 95% confidence intervals (CI) according to quartiles of DII, among 230 cases and 537 controls, overall and in strata of selected covariates. Italy, 1997–2007.

Cases/Controls DII quartiles Ptrend Pinteractiion OR (95% CI)d
< −1.47 −1.47,−0.14 −0.13,1.49 >1.49
Overall 230/547 1 a 1.17 (0.73, 1.85) 1.34 (0.81, 2.21) 2.35 (1.32, 4.20) 0.004 1.19 (1.06, 1.34)
Sex 0.53
 Male 142/283 1 a 1.17 (0.63, 2.15) 1.45 (0.75, 2.80) 2.15 (0.97, 4.79) 0.05 1.17 (0.99, 1.37)
 Female 87/261 1 a 1.04 (0.50, 2.18) 1.11 (0.50, 2.47) 2.57 (1.07, 6.18) 0.04 1.24 (1.03, 1.49)
Age (years) 0.44
 <65 105/252 1 a 1.01 (0.54, 1.89) 1.28 (0.63, 2.62) 2.85 (1.28, 6.34) 0.01 1.25 (1.06, 1.47)
 ≥65 125/295 1 a 1.35 (0.66, 2.75) 1.37 (0.66, 2.84) 1.83 (0.76, 4.44) 0.20 1.13 (0.95, 1.34)
Education (years) 0.67
 <7 95/235 1 a 1.16 (0.55, 2.46) 1.74 (0.77, 3.96) 3.64 (1.33, 9.96) 0.01 1.33 (1.08, 1.62)
 ≥7 135/309 1 a 1.29 (0.70, 2.37) 1.23 (0.64, 2.35) 2.20 (1.04, 4.67) 0.05 1.13 (0.97, 1.32)
BMI (kg/m2) 0.47
 <25 121/250 1 a 1.33 (0.66, 2.68) 2.10 (1.04, 4.27) 2.50 (1.12, 5.61) 0.01 1.22 (1.04, 1.44)
 ≥25 108/296 1 a 0.88 (0.46, 1.68) 0.75 (0.36, 1.58) 1.91 (0.79, 4.65) 0.21 1.13 (0.94, 1.35)
Smoking 0.86
 Never smokers 96/261 1 a 1.41 (0.69, 2.92) 1.39 (0.64, 3.02) 2.26 (0.96, 5.34) 0.07 1.18 (1.00, 1.40)
 Smokers 133/283 1 a 1.14 (0.61, 2.14) 1.39 (0.71, 2.73) 2.62 (1.16, 5.92) 0.03 1.20 (1.02, 1.41)
a

Reference category.

b

Estimated from multiple logistic regression models, conditioned on sex and quinquennia of age and adjusted for education, year of interview, body mass index (BMI), smoking, and total energy intake

c

Continuous OR for one unit increment of the DII, corresponding to ≈10% of its range (4.78 to −4.71).

Discussion

We observed positive associations between gastric cancer and inflammatory potential of diet as expressed by increasing DII in a southern European population. This result supports the hypothesis that individuals with a pro-inflammatory diet have a higher risk of developing gastric cancer.

Previous results from this study indicate foods such as vegetables and fruits and dietary patterns rich in these items, as well as various compounds, including flavonoids and proanthocyanidins to be inversely related to gastric cancer risk (46, 47). All of these dietary factors contribute to lower DII values (18). Conversely, dietary patterns rich in meats, animal fat, starchy food and refined cereals, which contribute to higher DII values (18), were positively related to gastric cancer risk (41). The apparently weaker effect among the obese could be explained by the fact that obesity in itself is a very pro-inflammatory condition (48, 49) thereby both exacerbating and masking the effects of pro-inflammatory diet. The stratified results, including those for BMI, should be viewed with caution because the test for heterogeneity was not significant because of small sample sizes within strata.

The positive relationship between increasing inflammatory potential of diet and gastric cancer is consistent with a body of evidence from previous studies examining the effect of various dietary components on gastric cancer. Several epidemiologic, experimental, and animal studies suggests that high intake of fresh fruits and vegetables, lycopene and lycopene-containing food products, and potentially vitamin C and selenium may reduce the risk for gastric cancer (10, 50) while high intake of nitrosamines, processed meat products, salt and salted foods, were associated with increased risk for gastric cancer (10, 50, 51). A systematic review and dose-response meta-analyses of prospective cohort studies indicated that a diet rich in fruit and white vegetable intake is associated with reduced risk of gastric cancer (50) while concordant positive association was observed with high-salt foods and alcohol intake (50). In a meta-analyses on dietary patterns, a ~2-fold lower gastric cancer risk for a ‘Prudent/healthy’ diet-rich in fruits and vegetables as compared to a ‘Western/unhealthy’ diet-rich in starchy foods, meat and fats was observed (52). In a case-control study from Uruguay, an increased risk of gastric cancer was observed for rice, salted meat, stewed meat, white bread, potatoes, and tubers. On the other hand, raw vegetables, total fruits, legumes, and black tea were inversely associated with gastric cancer risk (53). In another case-control study conducted in Siberia, increased intake of foods rich in carbohydrate, particularly mono- and disaccharides, as well as reduced consumption of food rich in polysaccharides, was associated with lower risk of diffuse type of gastric cancer (54). The diet and gastric cancer association has been less consistently reported in cohort studies (50, 55). The divergent results between case-control and cohort studies may be due to recall bias in retrospective studies. However, the association may have been underestimated in prospective studies because of the limited variability of dietary intakes within each cohort, and the changes in diet during the relatively long periods between data collection and disease occurrence (56).

One of the possible mechanisms through which the observed positive association between DII and gastric cancer risk could occur is through the effect of diet-related chronic inflammation in the upregulation of various cytokines and chemokines and the recruitment of numerous hematopoietic populations to inflamed gastric tissues. In addition, chronic inflammation stimulates the recruitment of progenitor cell populations to the stomach and their subsequent engraftment (13). Cytokines also can stimulate the recruitment and activation of inflammatory cells like neutrophils and macrophages, which when activated produce inflammatory mediators, including reactive oxygen species (ROS). These mediators impart oxidative stress on the cells in the gastric epithelium. Vitamin C, which is an important anti-inflammatory component, neutralizes this oxidative stress reaction (15, 57). Our results could be biased by the fact that cases were more likely to be smokers and smoking is a strongly pro-inflammatory state and is also a very well known risk factor for gastric cancer (58, 59).

The strengths of this study include the almost complete participation of both cases and controls, which should reduce the role of selection bias. Hospital controls may have different dietary habits as compared with the general population. However, we excluded from the comparison group subjects admitted for conditions associated with long-term dietary modifications (e.g., diabetes, cardiovascular diseases). Other strengths are the use of a reproducible and valid FFQ (42, 44) and the similar setting of interviews for cases and controls, which should limit information bias. Also, the DII score, which takes into account both pro- and anti-inflammatory food parameters that characterize virtually all human diets, accurately reflects the relationship of the inflammatory potential of whole diet. In addition to being subject to construct validation testing against inflammatory markers in both the SEASONS Study (19) and the Women’s Health Initiative (20), the DII previously has been shown to be associated with prostate, pancreatic, colorectal, endometrial, esophageal and hepatocellular cancers in a similar Italian population (22, 24, 32, 34, 60, 61).

Despite its strengths, this hospital study was based on a relatively small number of cases, thus not allowing meaningful analysis by separate histological type or tumour site. Further, we had no information on Helicobacter pylori infection, probably a necessary factor for gastric cancer (6, 62). It should be noted that any case-control study would have limited ability to measure H. pylori because blood samples obtained at cancer diagnosis are of limited value for ascribing exposure during the relevant etiologic period. As with all case-control studies, another limitation is the recall bias where participants had to remember what they ate 2 years prior to diagnosis. Given the limited knowledge and attention paid in the population to specific relations between diet and stomach cancer, bias in the recall of food intake by cases should be limited. The use of hospital controls may be criticized because their dietary habits may differ from those of the general population (45). However, given the same interview setting, information provided by hospital controls should be reasonably comparable with that obtained from cases (63).

In conclusion, this study indicates a potential role of inflammatory potential of diet on gastric cancer risk, more studies should be conducted on this topic to confirm this association.

Acknowledgments

Funding: This study was supported by the Italian Foundation for Research on Cancer (FIRC) and by the Italian Ministry of Health, General Directorate of European and International Relation. Drs. Shivappa and Hébert were supported by grant number R44DK103377 from the United States National Institute of Diabetes and Digestive and Kidney Diseases.

Footnotes

Disclosure: Dr. James R. Hébert owns controlling interest in Connecting Health Innovations LLC (CHI), a company planning to license the right to his invention of the dietary inflammatory index (DII) from the University of South Carolina in order to develop computer and smart phone applications for patient counseling and dietary intervention in clinical settings. Dr. Nitin Shivappa is an employee of CHI.

References

  • 1.Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer Journal international du cancer. 2015 Mar 1;136(5):E359–86. doi: 10.1002/ijc.29210. [DOI] [PubMed] [Google Scholar]
  • 2.Levi F, Lucchini F, Gonzalez JR, Fernandez E, Negri E, La Vecchia C. Monitoring falls in gastric cancer mortality in Europe. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. 2004 Feb;15(2):338–45. doi: 10.1093/annonc/mdh057. [DOI] [PubMed] [Google Scholar]
  • 3.Crew KD, Neugut AI. Epidemiology of gastric cancer. World journal of gastroenterology: WJG. 2006 Jan 21;12(3):354–62. doi: 10.3748/wjg.v12.i3.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Terry MB, Gaudet MM, Gammon MD. The epidemiology of gastric cancer. Seminars in radiation oncology. 2002 Apr;12(2):111–27. doi: 10.1053/srao.30814. [DOI] [PubMed] [Google Scholar]
  • 5.La Vecchia C, Franceschi S. Nutrition and gastric cancer with a focus on Europe. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation. 2000 Oct;9(5):291–5. doi: 10.1097/00008469-200010000-00001. [DOI] [PubMed] [Google Scholar]
  • 6.Boccia S, La Vecchia C. Dissecting causal components in gastric carcinogenesis. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation. 2013 Nov;22(6):489–91. doi: 10.1097/CEJ.0b013e3283603480. [DOI] [PubMed] [Google Scholar]
  • 7.de Mello VD, Schwab U, Kolehmainen M, Koenig W, Siloaho M, Poutanen K, et al. A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study. Diabetologia. 2011 Nov;54(11):2755–67. doi: 10.1007/s00125-011-2285-3. [DOI] [PubMed] [Google Scholar]
  • 8.Khoo J, Piantadosi C, Duncan R, Worthley SG, Jenkins A, Noakes M, et al. Comparing effects of a low-energy diet and a high-protein low-fat diet on sexual and endothelial function, urinary tract symptoms, and inflammation in obese diabetic men. J Sex Med. 2011 Oct;8(10):2868–75. doi: 10.1111/j.1743-6109.2011.02417.x. [DOI] [PubMed] [Google Scholar]
  • 9.Luciano M, Mottus R, Starr JM, McNeill G, Jia X, Craig LC, et al. Depressive symptoms and diet: their effects on prospective inflammation levels in the elderly. Brain Behav Immun. 2012 Jul;26(5):717–20. doi: 10.1016/j.bbi.2011.10.007. [DOI] [PubMed] [Google Scholar]
  • 10.Liu C, Russell RM. Nutrition and gastric cancer risk: an update. Nutrition reviews. 2008 May;66(5):237–49. doi: 10.1111/j.1753-4887.2008.00029.x. [DOI] [PubMed] [Google Scholar]
  • 11.Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002 Dec 19–26;420(6917):860–7. doi: 10.1038/nature01322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol. 2004 Dec;14(6):433–9. doi: 10.1016/j.semcancer.2004.06.006. [DOI] [PubMed] [Google Scholar]
  • 13.Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. The Journal of clinical investigation. 2007 Jan;117(1):60–9. doi: 10.1172/JCI30111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sepulveda AR. Helicobacter, Inflammation, and Gastric Cancer. Current pathobiology reports. 2013 Mar;1(1):9–18. doi: 10.1007/s40139-013-0009-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ernst P. Review article: the role of inflammation in the pathogenesis of gastric cancer. Alimentary pharmacology & therapeutics. 1999 Mar;13( Suppl 1):13–8. doi: 10.1046/j.1365-2036.1999.00003.x. [DOI] [PubMed] [Google Scholar]
  • 16.Feng B, Fan Y, Wang W, Yao G, Zhai J. IL-17A G197A and C1249T polymorphisms in gastric carcinogenesis. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014 Oct;35(10):9977–85. doi: 10.1007/s13277-014-2288-z. [DOI] [PubMed] [Google Scholar]
  • 17.Yu Q, Yu XF, Zhang SD, Wang HH, Wang HY, Teng LS. Prognostic role of C-reactive protein in gastric cancer: a meta-analysis. Asian Pacific journal of cancer prevention: APJCP. 2013;14(10):5735–40. doi: 10.7314/apjcp.2013.14.10.5735. [DOI] [PubMed] [Google Scholar]
  • 18.Shivappa N, Steck SE, Hurley TG, Hussey JR, Hebert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public health nutrition. 2014 Aug;17(8):1689–96. doi: 10.1017/S1368980013002115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Shivappa N, Steck SE, Hurley TG, Hussey JR, Ma Y, Ockene IS, et al. A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal Variation of Blood Cholesterol Study (SEASONS) Public health nutrition. 2014 Aug;17(8):1825–33. doi: 10.1017/S1368980013002565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Tabung FK, Steck SE, Zhang J, Ma Y, Liese AD, Agalliu I, et al. Construct validation of the dietary inflammatory index among postmenopausal women. Annals of epidemiology. 2015 Jun;25(6):398–405. doi: 10.1016/j.annepidem.2015.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ruiz-Canela M, Zazpe I, Shivappa N, Hebert JR, Sanchez-Tainta A, Corella D, et al. Dietary inflammatory index and anthropometric measures of obesity in a population sample at high cardiovascular risk from the PREDIMED (PREvencion con DIeta MEDiterranea) trial. The British journal of nutrition. 2015 Feb;27:1–12. doi: 10.1017/S0007114514004401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wirth MD, Burch J, Shivappa N, Violanti JM, Burchfiel CM, Fekedulegn D, et al. Association of a dietary inflammatory index with inflammatory indices and metabolic syndrome among police officers. Journal of occupational and environmental medicine/American College of Occupational and Environmental Medicine. 2014 Sep;56(9):986–9. doi: 10.1097/JOM.0000000000000213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Neufcourt L, Assmann KE, Fezeu LK, Touvier M, Graffouillere L, Shivappa N, et al. Prospective association between the dietary inflammatory index and metabolic syndrome: Findings from the SU.VI.MAX study. Nutr Metab Cardiovasc Dis. 2015 Sep 21;21(15):002. doi: 10.1016/j.numecd.2015.09.002. Dietary inflammatory index Metabolic syndrome Prospective study. [DOI] [PubMed] [Google Scholar]
  • 24.Alkerwi A, Shivappa N, Crichton G, Hebert JR. No significant independent relationships with cardiometabolic biomarkers were detected in the Observation of Cardiovascular Risk Factors in Luxembourg study population. Nutrition research. 2014 Dec;34(12):1058–65. doi: 10.1016/j.nutres.2014.07.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ruiz-Canela M, Zazpe I, Shivappa N, Hebert JR, Sanchez-Tainta A, Corella D, et al. Dietary inflammatory index and anthropometric measures of obesity in a population sample at high cardiovascular risk from the PREDIMED (PREvencion con DIeta MEDiterranea) trial. The British journal of nutrition. 2015 Mar 28;113(6):984–95. doi: 10.1017/S0007114514004401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Garcia-Arellano A, Ramallal R, Ruiz-Canela M, Salas-Salvado J, Corella D, Shivappa N, et al. Dietary Inflammatory Index and Incidence of Cardiovascular Disease in the PREDIMED Study. Nutrients. 2015 Jun;7(6):4124–38. doi: 10.3390/nu7064124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ramallal R, Toledo E, Martinez-Gonzalez MA, Hernandez-Hernandez A, Garcia-Arellano A, Shivappa N, et al. Dietary Inflammatory Index and Incidence of Cardiovascular Disease in the SUN Cohort. PloS one. 2015;10(9):e0135221. doi: 10.1371/journal.pone.0135221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Shivappa N, Hebert JR, Rietzschel ER, De Buyzere ML, Langlois M, Debruyne E, et al. Associations between dietary inflammatory index and inflammatory markers in the Asklepios Study. The British journal of nutrition. 2015 Feb;113(4):665–71. doi: 10.1017/S000711451400395X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Wirth MD, Shivappa N, Steck SE, Hurley TG, Hebert JR. The dietary inflammatory index is associated with colorectal cancer in the National Institutes of Health-American Association of Retired Persons Diet and Health Study. The British journal of nutrition. 2015 Jun 14;113(11):1819–27. doi: 10.1017/S000711451500104X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Tabung FK, Steck SE, Ma Y, Liese AD, Zhang J, Caan B, et al. The association between dietary inflammatory index and risk of colorectal cancer among postmenopausal women: results from the Women’s Health Initiative. Cancer causes & control: CCC. 2015 Mar;26(3):399–408. doi: 10.1007/s10552-014-0515-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Shivappa N, Prizment AE, Blair CK, Jacobs DR, Jr, Steck SE, Hebert JR. Dietary inflammatory index and risk of colorectal cancer in the Iowa Women’s Health Study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2014 Nov;23(11):2383–92. doi: 10.1158/1055-9965.EPI-14-0537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zamora-Ros R, Shivappa N, Steck SE, Canzian F, Landi S, Alonso MH, et al. Dietary inflammatory index and inflammatory gene interactions in relation to colorectal cancer risk in the Bellvitge colorectal cancer case-control study. Genes & nutrition. 2015 Jan;10(1):447. doi: 10.1007/s12263-014-0447-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Shivappa N, Zucchetto A, Montella M, Serraino D, Steck SE, La Vecchia C, et al. Inflammatory potential of diet and risk of colorectal cancer: a case-control study from Italy. The British journal of nutrition. 2015 Jul 14;114(1):152–8. doi: 10.1017/S0007114515001828. [DOI] [PubMed] [Google Scholar]
  • 34.Shivappa N, Zucchetto A, Serraino D, Rossi M, La Vecchia C, Hebert JR. Dietary inflammatory index and risk of esophageal squamous cell cancer in a case-control study from Italy. Cancer causes & control: CCC. 2015 Oct;26(10):1439–47. doi: 10.1007/s10552-015-0636-y. [DOI] [PubMed] [Google Scholar]
  • 35.Lu Y, Shivappa N, Lin Y, Lagergren J, Hebert JR. Diet-related inflammation and oesophageal cancer by histological type: a nationwide case-control study in Sweden. European journal of nutrition. 2015 Jul 19; doi: 10.1007/s00394-015-0987-x. [DOI] [PubMed] [Google Scholar]
  • 36.Shivappa N, Hebert JR, Rashidkhani B. Dietary Inflammatory Index and Risk of Esophageal Squamous Cell Cancer in a Case-Control Study from Iran. Nutrition and cancer. 2015 Sep;23:1–7. doi: 10.1080/01635581.2015.1082108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Shivappa N, Bosetti C, Zucchetto A, Serraino D, La Vecchia C, Hebert JR. Dietary inflammatory index and risk of pancreatic cancer in an Italian case-control study. The British journal of nutrition. 2014 Dec;17:1–7. doi: 10.1017/S0007114514003626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Shivappa N, Blair CK, Prizment AE, Jacobs DR, Jr, Steck SE, Hebert JR. Association between inflammatory potential of diet and mortality in the Iowa Women’s Health study. European journal of nutrition. 2015 Jul 1; doi: 10.1007/s00394-015-0967-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Shivappa N, Harris H, Wolk A, Hebert JR. Association between inflammatory potential of diet and mortality among women in the Swedish Mammography Cohort. European journal of nutrition. 2015 Jul 31; doi: 10.1007/s00394-015-1005-z. [DOI] [PubMed] [Google Scholar]
  • 40.Shivappa N, Steck S, Hussey J, Ma Y, Hebert J. Inflammatory potential of diet and all-cause, cardiovascular, and cancer mortality in National Health and Nutrition Examination Survey III Study. European journal of nutrition. 2015 Dec 07;:1–10. doi: 10.1007/s00394-015-1112-x. English. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Lucenteforte E, Scita V, Bosetti C, Bertuccio P, Negri E, La Vecchia C. Food groups and alcoholic beverages and the risk of stomach cancer: a case-control study in Italy. Nutrition and cancer. 2008;60(5):577–84. doi: 10.1080/01635580802054512. [DOI] [PubMed] [Google Scholar]
  • 42.Franceschi S, Negri E, Salvini S, Decarli A, Ferraroni M, Filiberti R, et al. Reproducibility of an Italian food frequency questionnaire for cancer studies: results for specific food items. Eur J Cancer. 1993;29A(16):2298–305. doi: 10.1016/0959-8049(93)90225-5. Epub 1993/01/01. eng. [DOI] [PubMed] [Google Scholar]
  • 43.Franceschi S, Barbone F, Negri E, Decarli A, Ferraroni M, Filiberti R, et al. Reproducibility of an Italian food frequency questionnaire for cancer studies. Results for specific nutrients. Ann Epidemiol. 1995 Jan;5(1):69–75. doi: 10.1016/1047-2797(95)92893-d. Epub 1995/01/01. eng. [DOI] [PubMed] [Google Scholar]
  • 44.Decarli A, Franceschi S, Ferraroni M, Gnagnarella P, Parpinel MT, La Vecchia C, et al. Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol. 1996 Mar;6(2):110–8. doi: 10.1016/1047-2797(95)00129-8. Epub 1996/03/01. eng. [DOI] [PubMed] [Google Scholar]
  • 45.Breslow NEDN. Statistical methods in cancer research-The analysis of case-control studies. 32. I. IARC Sci Publs; 1980. [PubMed] [Google Scholar]
  • 46.Bertuccio P, Edefonti V, Bravi F, Ferraroni M, Pelucchi C, Negri E, et al. Nutrient dietary patterns and gastric cancer risk in Italy. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2009 Nov;18(11):2882–6. doi: 10.1158/1055-9965.EPI-09-0782. [DOI] [PubMed] [Google Scholar]
  • 47.Rossi M, Rosato V, Bosetti C, Lagiou P, Parpinel M, Bertuccio P, et al. Flavonoids, proanthocyanidins, and the risk of stomach cancer. Cancer causes & control: CCC. 2010 Oct;21(10):1597–604. doi: 10.1007/s10552-010-9588-4. [DOI] [PubMed] [Google Scholar]
  • 48.Shehzad A, Ha T, Subhan F, Lee YS. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. European journal of nutrition. 2011 Apr;50(3):151–61. doi: 10.1007/s00394-011-0188-1. [DOI] [PubMed] [Google Scholar]
  • 49.Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annual review of immunology. 2011;29:415–45. doi: 10.1146/annurev-immunol-031210-101322. [DOI] [PubMed] [Google Scholar]
  • 50.Fang X, Wei J, He X, An P, Wang H, Jiang L, et al. Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studies. Eur J Cancer. 2015 Dec;51(18):2820–32. doi: 10.1016/j.ejca.2015.09.010. [DOI] [PubMed] [Google Scholar]
  • 51.Song P, Wu L, Guan W. Dietary Nitrates, Nitrites, and Nitrosamines Intake and the Risk of Gastric Cancer: A Meta-Analysis. Nutrients. 2015;7(12):9872–95. doi: 10.3390/nu7125505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Bertuccio P, Rosato V, Andreano A, Ferraroni M, Decarli A, Edefonti V, et al. Dietary patterns and gastric cancer risk: a systematic review and meta-analysis. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. 2013 Jun;24(6):1450–8. doi: 10.1093/annonc/mdt108. [DOI] [PubMed] [Google Scholar]
  • 53.De Stefani E, Correa P, Boffetta P, Deneo-Pellegrini H, Ronco AL, Mendilaharsu M. Dietary patterns and risk of gastric cancer: a case-control study in Uruguay. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2004;7(4):211–20. doi: 10.1007/s10120-004-0295-2. [DOI] [PubMed] [Google Scholar]
  • 54.Lazarevic K, Nagorni A, Jeremic M. Carbohydrate intake, glycemic index, glycemic load and risk of gastric cancer. Central European journal of public health. 2009 Jun;17(2):75–8. doi: 10.21101/cejph.a3501. [DOI] [PubMed] [Google Scholar]
  • 55.Lunet N, Lacerda-Vieira A, Barros H. Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies. Nutrition and cancer. 2005;53(1):1–10. doi: 10.1207/s15327914nc5301_1. [DOI] [PubMed] [Google Scholar]
  • 56.Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr. 2003 Sep;78(3 Suppl):559S–69S. doi: 10.1093/ajcn/78.3.559S. [DOI] [PubMed] [Google Scholar]
  • 57.La Vecchia C, Ferraroni M, D’Avanzo B, Decarli A, Franceschi S. Selected micronutrient intake and the risk of gastric cancer. Cancer Epidemiology Biomarkers & Prevention. 1994 Jul 1;3(5):393–8. [PubMed] [Google Scholar]
  • 58.Lee YY, Derakhshan MH. Environmental and lifestyle risk factors of gastric cancer. Archives of Iranian medicine. 2013 Jun;16(6):358–65. [PubMed] [Google Scholar]
  • 59.Gonzalez CA, Lopez-Carrillo L. Helicobacter pylori, nutrition and smoking interactions: their impact in gastric carcinogenesis. Scandinavian journal of gastroenterology. 2010;45(1):6–14. doi: 10.3109/00365520903401959. [DOI] [PubMed] [Google Scholar]
  • 60.Shivappa N, Hebert JR, Polesel J, Zucchetto A, Crispo A, Montella M, et al. Inflammatory potential of diet and risk for hepatocellular cancer in a case-control study from Italy. The British journal of nutrition. 2015 Nov;11:1–8. doi: 10.1017/S0007114515004419. [DOI] [PubMed] [Google Scholar]
  • 61.Shivappa N, Hébert JR, Zucchetto A, Montella M, Serraino D, La Vecchia C, et al. Dietary inflammatory index and endometrial cancer risk in an Italian case–control study. British Journal of Nutrition. 2015 doi: 10.1017/S0007114515004171. FirstView:1–9. [DOI] [PubMed] [Google Scholar]
  • 62.Peleteiro B, La Vecchia C, Lunet N. The role of Helicobacter pylori infection in the web of gastric cancer causation. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation. 2012 Mar;21(2):118–25. doi: 10.1097/CEJ.0b013e32834a7f66. [DOI] [PubMed] [Google Scholar]
  • 63.D’Avanzo B, La Vecchia C, Katsouyanni K, Negri E, Trichopoulos D. An assessment, and reproducibility of food frequency data provided by hospital controls. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation. 1997 Jun;6(3):288–93. doi: 10.1097/00008469-199706000-00006. [DOI] [PubMed] [Google Scholar]

RESOURCES